Gitadenta - Company finances
|
EUR
|
2024
From: 2024-06-04
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|
|
Financial data
|
||
| Sales revenue | 36,810 | 88,720 |
| Profit before tax | 5,561 | 18,342 |
| Net profit | 5,561 | 17,178 |
| Equity | 5,661 | 17,279 |
| Liabilities | 1,257 | - |
| Non-current assets | 0 | 2,814 |
| Current assets | 6,918 | 18,066 |
| Total assets | 6,918 | 20,880 |
|
Taxes paid
|
||
| STI taxes | 2,918 | 3,615 |
|
Financial indicators
|
||
| Revenue change y/y | - | +141.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 80.4% | 82.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 98.2% | 99.4% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 15.1% | 19.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 15.1% | 20.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 36,810 | 88,720 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Gitadenta - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-01-16 | 2025-01-19 | 95.06 |
Gitadenta - VMI tax arrears
As of 2026-09-14, the amount of overdue STI tax debt of the company Gitadenta is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-06-18 | 2026-09-14 | 0.08 |
| 2025-02-18 | 2026-04-13 | 0.08 |
| 2025-01-06 | 2025-01-15 | 0.08 |
| 2024-12-17 | 2024-12-17 | 0.08 |
| 2024-11-12 | 2024-11-17 | 0.08 |
| 2024-10-04 | 2024-10-16 | 0.08 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Gitadenta, MB (code 306815274) is a Small partnership engaged in Medical specialists activities. In 2025, the company generated revenue of €88.7K and net profit of €17.2K, up from €36.8K of revenue and €5.6K of net profit in 2024. Revenue growth year on year was 141.0%, and profitability also improved, with the net margin rising from 15.1% in 2024 to 19.4% in 2025. The 2024 figures cover a 210-day period, while 2025 reflects a full 364-day year, so the latest results are more comparable on an annual basis. At the end of 2025, total assets stood at €20.9K, supported by equity of €17.3K and liabilities of €3.6K. The balance sheet remained conservatively financed, with an equity ratio of 82.8% and debt-to-equity of 0.21. Asset turnover was 4.25x, indicating efficient use of assets. Revenue per employee was €88.7K and profit per employee was €17.2K, pointing to solid operating productivity.